QIAGEN’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

QIAGEN is a biotechnology company that provides molecular diagnostics and sample preparation solutions for the healthcare industry. Read more

12,844 Followers on Owler
12,844 Followers on Owler
12,844 Followers on Owler
12,844 Followers on Owler

QIAGEN is a biotechnology company that provides molecular diagnostics and sample preparation solutions for the healthcare industry. Read more

Thierry Bernard's photo - CEO of QIAGEN

CEO

Thierry Bernard

CEO Approval Rating

52/100

Founded:

1984

Status:

PublicIndependent CompanyNYSEQGEN

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Illumina is QIAGEN's #1 rival. Illumina is a Public company that was founded in San Diego, California in 1998. Like QIAGEN, Illumina also works within the Biotechnology field. Illumina has 3,016 more employees vs. QIAGEN.

NEB is perceived as one of QIAGEN's biggest rivals. NEB was founded in 1974, and is headquartered in Ipswich, Massachusetts. Like QIAGEN, NEB also operates in the Biotechnology sector. NEB generates $1.3B less revenue vs. QIAGEN.

Roche is a top competitor of QIAGEN. Roche is a Public company that was founded in 1896 in Basel, Basel-Country. Like QIAGEN, Roche also operates in the Biotechnology space. Compared to QIAGEN, Roche has 93,316 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Omega Biotek a competitor of QIAGEN?

Quarterly and Annual Revenue

Coming soon for QIAGEN!

Annual Revenue

$1.6B

QIAGEN's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 3.1B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
NeuMoDx Molecular, Inc.

Sep 2020

Source »
$248M
NeuMoDx is a diagnostics company that offers vitro molecular diagnostic testing solutions for hospitals and clinical laboratories.
N-of-One, Inc.

Jan 2019

Source »
undisclosed
N-of-One is an oncology diagnostics platform that enables clinical interpretation of molecular tests.

-

-

Jan 2018

Source »
$191M
-
Omicsoft Corporation

Jan 2017

Source »
undisclosed
OmicSoft is a provider of bioinformatics, sequencing and cancer genomics solutions for scientists and researchers.
CLC bio

Oct 2013

Source »
undisclosed
CLC bio is the bioinformatics analysis platform that provides integrated desktop and server software solutions.

These are all the companies that QIAGEN has acquired. QIAGEN has acquired 10 companies and its latest acquisition was NeuMoDx Molecular, Inc. in Sep 2020. NeuMoDx is a diagnostics company that offers vitro molecular diagnostic testing solutions for hospitals and clinical laboratories.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Exosome is focused on developing and commercializing biofluid-based diagnostics solutions to deliver personalized precision healthcare.
$16M
Jan 06, 2016
Series B
Jun 01, 2018
Protagen develops diagnostic tools for the treatment of autoimmune diseases.
$4.7M
Dec 15, 2014
Seed
Mar 01, 2019
Curetis is a molecular diagnostics company that develops tools to test infectious diseases.
$18M
Nov 23, 2014
Series B
Sep 01, 2019
AyoxxA is a biotechnology company that develops a platform for multiplexed protein analysis to measure proteins and biomolecular analytes.
$12.3M
Jun 29, 2014
Series B
-
Exosome is focused on developing and commercializing biofluid-based diagnostics solutions to deliver personalized precision healthcare.
$27.1M
Mar 10, 2014
Series B
Jun 01, 2018

These are all the companies that QIAGEN has invested in. QIAGEN has invested 10 companies and its latest investment was NeuMoDx Molecular, Inc. in Sep 2020. NeuMoDx is a diagnostics company that offers vitro molecular diagnostic testing solutions for hospitals and clinical laboratories.

QIAGEN News

November 20, 2020Medical Buyer

BioNTech partners with Qiagen on head, neck cancer CDx

BioNTech and Qiagen have announced a strategic collaboration to develop and commercialise tissue-base... See more »
November 18, 2020Medical Buyer

Qiagen rolls out multiplex test for seasonal infections and COVID-19 in Europe

Qiagen has launched its NeuMoDx Flu A-B/RSV/SARS-CoV-2 vantage test for rapid identification and diff... See more »
November 18, 2020Pharmabiz

Qiagen launches NeuMoDx Flu AB/RSV/SARSCoV2 Vantage Test in Europe

Qiagen announced the European launch of the NeuMoDx Flu A─B/RSV/SARS─CoV─2 Vantage Test that will hel... See more »
November 17, 2020Clinical Lab Products

TScan Therapeutics, Qiagen to Develop T-Cell Test from Covid-19 Immune Response

The covid-19 laboratory tests will use discoveries from TScan's high-throughput TCR/Target discovery ... See more »
November 14, 2020Clinical Lab Products

Qiagen Portable Digital Covid-19 Antigen Test Accurately Analyzes Over 30 Samples Per Hour

Testing of clinical samples has shown the QiaReach SARS-CoV-2 Antigen Test to have a sensitivity of 9... See more »

QIAGEN Press Releases

January 14, 2019StreetInsider

QIAGEN's QuantiFERON®-TB Gold Plus Gains Approval in Canada

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standar... See more »
August 1, 2018Accesswire

QIAGEN NV to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 1, 2018 / QIAGEN NV (NYSE: QGEN) will be discussing their earnings... See more »
January 19, 2018Industry Today

Key Players - Spectra Laboratories, Sonic Healthcare Ltd., Siemens, Quest Diagnostics, Qiagen

Clinical Laboratory Services -Market Demand, Growth, Opportunities and Analysis Of Top Key Player For... See more »
December 28, 2017ForImmediateRelease

Real-time PCR (qPCR) andDigital PCR (dPCR) Market - Expected to Reach $6.3 Billion by 2025

Travel & Tourism Industry release: The global real time PCR (qPCR) and digital PCR (dPCR) market is e... See more »
October 30, 2017ePress Release

Global Circulating Biomarker Market 2017 - Biocept Inc, Myriad Genetics, QIAGEN, Roche

The report on Global Circulating Biomarker Market offers key insights for the overall industry with m... See more »
October 19, 2017PR Newswire

QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening

ORLANDO, GERMANTOWN, Maryland, and HILDEN, Germany, October 19, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: ... See more »

QIAGEN Videos

May 3, 2020QIAGEN Vimeo Channel

"QIAseq solutions for studying SARS-CoV-2 and its effects using next-generation sequencing (NGS)" on VIMEO

The seismic effects of the COVID-19 pandemic have affected not only public health but society in an u... See more »
April 29, 2020QIAGEN Vimeo Channel

"Innovative one-day workflow for simultaneous high-sensitivity profiling of DNA variants and RNA fusions" on VIMEO

Cancer is a highly complexdisease and understanding the various alterations that together determineme... See more »
April 2, 2020QIAGEN Vimeo Channel

"Gene expression profiling: Getting meaningful insights from low-quantity samples" on VIMEO

Gene expression profiling using RNA-seq has opened up new applications and given researchers access t... See more »
January 31, 2020QIAGEN Vimeo Channel

"Advantages of digital PCR and its applications - the power of partitioning" on VIMEO

The versatility of standard PCR and qPCR is well known. Digital PCR is now taking this to a whole new... See more »
December 10, 2019QIAGEN Vimeo Channel

"QIAGEN's new dPCR portfolio - overcoming the current throughput, speed and usability bottlenecks in digital PCR" on VIMEO

Digital PCR (dPCR) is a highly viable solution for copy number variation (CNV) detection, rare mutati... See more »

Social Media

Headquarters

Qiagen Strabe 1

Hilden, North Rhine-Westphalia40724

49-2103-29-0

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

QIAGEN is a biotechnology company that provides molecular diagnostics and sample preparation solutions for the healthcare industry. QIAGEN was founded in 1984. QIAGEN's headquarters is located in Hilden, North Rhine-Westphalia, DE 40724. QIAGEN's CEO...

CEO

QIAGEN's CEO, Thierry Bernard, currently has an approval rating of 52%. QIAGEN's primary competitors are Illumina, NEB & Roche.

Website

qiagen.com

Frequently Asked Questions about QIAGEN

  1. When was QIAGEN founded?

    QIAGEN was founded in 1984
  2. Who is QIAGEN's CEO?

    QIAGEN's CEO is Thierry Bernard
  3. How much revenue does QIAGEN generate?

    QIAGEN generates $1.6B in revenue
  4. How much funding does QIAGEN have?

    QIAGEN has historically raised $0 in funding
  5. Where is QIAGEN's headquarters?

    QIAGEN's headquarters is in Hilden North Rhine-Westphalia, DE
  1. How many employees does QIAGEN have?

    QIAGEN has 4,684 employees
  2. What sector does QIAGEN operate in?

    QIAGEN is in Biotechnology
  3. Who are QIAGEN's competitors?

    QIAGEN's top competitors are Illumina, NEB, Roche
  4. Who has QIAGEN invested in?

    QIAGEN's has invested in companies such as Exosome Diagnostics, Protagen, Curetis